Publications dans lesquelles il/elle collabore avec Leandro Francisco Fernández Pérez (16)

2022

  1. Design, Semisynthesis, and Estrogenic Activity of Lignan Derivatives from Natural Dibenzylbutyrolactones

    Pharmaceuticals, Vol. 15, Núm. 5, pp. 585

  2. Discovery of Highly Functionalized 5-hydroxy-2H-pyrrol-2-ones That Exhibit Antiestrogenic Effects in Breast and Endometrial Cancer Cells and Potentiate the Antitumoral Effect of Tamoxifen

    Cancers, Vol. 14, Núm. 21

2021

  1. JKST6, a novel multikinase modulator of the BCR-ABL1/STAT5 signaling pathway that potentiates direct BCR-ABL1 inhibition and overcomes imatinib resistance in chronic myelogenous leukemia

    Biomedicine and Pharmacotherapy, Vol. 144

  2. Modular synthesis and antiproliferative activity of new dihydro-1H-pyrazolo[1,3-b]pyridine embelin derivatives

    Pharmaceuticals, Vol. 14, Núm. 10

2019

  1. A novel naphthoquinone-coumarin hybrid that inhibits BCR-ABL1-STAT5 oncogenic pathway and reduces survival in imatinib-resistant chronic myelogenous leukemia cells

    Frontiers in Pharmacology, Vol. 9, Núm. JAN

  2. Signal transducer and activator of transcription (STAT)-5: an opportunity for drug development in oncohematology

    Oncogene, Vol. 38, Núm. 24, pp. 4657-4668

  3. Synthesis and antiplasmodial activity of 1,2,3-triazole-naphthoquinone conjugates

    Molecules, Vol. 24, Núm. 21

  4. Synthesis, characterization and antiproliferative activity of mixed ligand complexes of Cu2+ and Co2+ with lapachol

    Polyhedron, Vol. 165, pp. 73-78

2018

  1. Correction: CM363, a novel naphthoquinone derivative which acts as multikinase modulator and overcomes imatinib resistance in chronic myelogenous leukemia [Oncotarget, 8 (2017) (29679-29698)] Doi: 10.18632/oncotarget.11425

    Oncotarget

  2. Lawsone, Juglone, and β-Lapachone Derivatives with Enhanced Mitochondrial-Based Toxicity

    ACS Chemical Biology, Vol. 13, Núm. 8, pp. 1950-1957

2017

  1. 5-Ethynylarylnaphthalimides as antitumor agents: Synthesis and biological evaluation

    Bioorganic and Medicinal Chemistry, Vol. 25, Núm. 6, pp. 1976-1983

  2. CM363, a novel naphthoquinone derivative which acts as multikinase modulator and overcomes imatinib resistance in chronic myelogenous leukemia

    Oncotarget, Vol. 8, Núm. 18, pp. 29679-29698

2015

  1. Synthesis of 4,4′-Diaminotriphenylmethanes with Potential Selective Estrogen Receptor Modulator (SERM)-like Activity

    ChemMedChem, Vol. 10, Núm. 8, pp. 1403-1412

2014

  1. Indium catalyzed solvent-free multicomponent synthesis of cytotoxic dibenzo[a,h]anthracenes from aldehydes, 2-hydroxy-1,4-naphthoquinone, and 2-naphthol

    Tetrahedron, Vol. 70, Núm. 45, pp. 8480-8487

2013

  1. Synthesis and study of antiproliferative, antitopoisomerase II, DNA-intercalating and DNA-damaging activities of arylnaphthalimides

    Bioorganic and Medicinal Chemistry, Vol. 21, Núm. 21, pp. 6484-6495

2010

  1. Cytotoxic triterpenoids from Maytenus retusa

    Journal of Natural Products, Vol. 73, Núm. 12, pp. 2029-2034